Service from the Office of Special Trustee for American Indians. The amendment would increase funding for the Indian Health Service by $79.2 million, with $63 million designated for clinical services. It would be offset by transferring $79.2 million from the Office of Special Trustee for American Indians. [Vote 362, 9/23/03] XXXX Voted For Increasing Funding For The Indian Health Service. In 2000, XXXX voted for an amendment that would increase the appropriation for the Indian Health Service by $7.372 million for diabetes treatment, prevention, and research, and would offset the cost of that increase by cutting the appropriation for the National Endowment for the Arts (NEA) by the same amount (which would leave NEA funding at its current level of $97 million). The amendment was rejected, 27-73. [Vote 176, 7/12/00] MEDICAL RESEARCH XXXX Voted Against $1.5 Billion for NIH. In March 2005, XXXX voted against an amendment that increased fiscal 2006 funding for the National Institutes of Health by $1.5 billion and education funding by $500 million. The amendment was offset by a $2 billion cut in the Allowances account. [Vote 56, 3/16/05] XXXX Opposed Raising Cigarette Taxes to Pay for Health Services. In 2004, XXXX voted against an amendment to provide $2 billion for deficit reduction and $30.5 billon over five years for medical research and health services, such as tobacco cessation programs, mental health programs, and substance abuse programs, with the $32.5 billion offset by increasing the cigarette tax by 61 cents per pack. [Vote 46, 3/11/04] XXXX Voted For $2 Billion in Increased Funding for Health Care Research. In 2004, XXXX voted for an amendment that increased funding for the National Institutes of Health by $2 billion. [Vote 56, 3/11/04] XXXX Supported $1.5 Billion in Funding for the National Institutes of Health. In 2003, XXXX voted for an amendment that would have added $1.5 billion in funding for the National Institutes of Health by designating the extra spending as an “emergency spending measure under the budget resolution.” The amendment would have provided an additional $1.5 billion in funding for the National Institutes of Health and designated the additional funding as emergency spending. The substitute amendment provided $137.6 billion in discretionary spending in fiscal 2004 for the Labor, Health and Human Services and Education departments and related agencies. [Vote 346, 9/10/03; CQ Daily Monitor, 9/10/03] XXXX Voted To Increase Funding For The NIH. In 2001, XXXX voted for an amendment to increase the Health function for FY 2002 by $700 million with the intention of increasing funding for the National Institutes of Health (NIH). It would offset the cost by decreasing the Allowances function (920) by the same amount (the Allowances function covers administrative costs). The amendment was agreed to, 96-4. [H Con Res 831, Vote 70, 4/4/0] XXXX Voted Against Requiring Prescription Drug Companies to Sell NIH-Patented Products At a Reasonable Price. In 2000, XXXX voted against prohibiting the National Institutes of Health (NIH) from granting a patent for, or exclusive right to, a drug developed by the NIH unless the company receiving the patent or exclusive right agreed to sell the drug at a “reasonable” price. The vote was on tabling the Wellstone amendment to the Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Bill for fiscal year 2001. [Vote 168, 6/30/00] XXXX Voted To Earmark Funding For Antimicrobial Research. In 2000, XXXX voted for an amendment that would earmark $25 million to establish partnerships between the Federal Government, academic institutions, and State and local public health departments to carry out pilot programs for antimicrobial resistance detection, surveillance, education, and prevention and to conduct research on resistance mechanisms and new or more effective antimicrobial compounds. The amendment was agreed to, 96-0. [Vote 145, 6/27/00] XXXX Voted to Guarantee Patients Access to Clinical Trials. In 1999, XXXX voted for an amendment that provides coverage for individuals participating in approved clinical trials and for approved drugs and medical devices. The amendment also requires that all patients with private health insurance be provided with inpatient 186